Prophylactic low-dose hydrocortisone treatment increases the rate of survival without bronchopulmonary dysplasia in extremely preterm infants

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)177
JournalEvidence-based medicine
Volume21
Issue number5
DOIs
Publication statusPublished - 2016

Cite this